High Plasma Levels of Islet Amyloid Polypeptide in Young with New-Onset of Type 1 Diabetes Mellitus

Aims/Hypothesis Islet amyloid polypeptide (IAPP) is a beta cell hormone secreted together with insulin upon glucose stimulation. IAPP participates in normal glucose regulation, but IAPP is also known for its ability to misfold and form islet amyloid. Amyloid fibrils form through smaller cell toxic intermediates and deposited amyloid disrupts normal islet architecture. Even though IAPP and amyloid formation are much discussed in type 2 diabetes, our aim was to study the significance of IAPP in type 1 diabetes. Results Plasma IAPP levels in children and adolescents with newly diagnosed type 1 diabetes (n = 224) were analysed and concentrations exceeding 100 pmol/L (127.2 – 888.7 pmol/L) were found in 11% (25/224). The IAPP increase did not correlate with C-peptide levels. Conclusions/Interpretation Plasma levels of IAPP and insulin deviate in a subpopulation of young with newly-diagnosed type 1 diabetes. The determined elevated levels of IAPP might increase the risk for IAPP misfolding and formation of cell toxic amyloid in beta cells. This finding add IAPP-aggregation to the list over putative pathological factors causing type 1 diabetes.

• Publication year

  2014

• Venue

  PLoS ONE

• Publication date

  2014-03-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1371/journal.pone.0093053PMID 24671002PMCID 3966843
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic β-cells: protective role of p62-positive cytoplasmic inclusions

  2011cited by this paper
• A Chronic Autoimmune Disease

  2009cited by this paper
• Analysis of islet inflammation in human type 1 diabetes

  2009cited by this paper
• Widespread amyloid deposition in transplanted human pancreatic islets.

  2008cited by this paper
• Real-Time Monitoring of Apoptosis by Caspase-3-Like Protease Induced FRET Reduction Triggered by Amyloid Aggregation

  2008cited by this paper
• Screening for Insulitis in Adult Autoantibody-Positive Organ Donors

  2007cited by this paper
• Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.

  2006cited by this paper
• Autoantibodies in diabetes

  2006cited by this paper
• β-Cell Deficit Due to Increased Apoptosis in the Human Islet Amyloid Polypeptide Transgenic (HIP) Rat Recapitulates the Metabolic Defects Present in Type 2 Diabetes

  2006cited by this paper
• Autoantibodies in diabetes.

  2005cited by this paper
• Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation.

  2005cited by this paper
• Islet amyloid polypeptide in insulinoma and in the islets of the pancreas of non-diabetic and diabetic subjects

  2005cited by this paper
• Autoimmune Destruction of Pancreatic β Cells

  2005cited by this paper
• Heterophile antibodies masquerade as interferon-alpha in subjects with new-onset type 1 diabetes.

  2004cited by this paper
• Heterophile Antibodies Masquerade as Interferon-α in Subjects With New-Onset Type 1 Diabetes

  2004cited by this paper
• Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes.

  2002cited by this paper
• Immunometric assay interference: incidence and prevention.

  2002cited by this paper
• Role of amylin in insulin secretion and action in humans: antagonist studies across the spectrum of insulin sensitivity

  2002cited by this paper
• Development of type 1 diabetes despite severe hereditary B-cell deficiency.

  2001cited by this paper
• Coexpression of receptors for adrenomedullin, calcitonin gene-related peptide, and amylin in pancreatic beta-cells.

  2000cited by this paper
• Development of type 1 diabetes despite severe hereditary B lymphocyte deficiency: No pathogenic role of B lymphocytes

  2000cited by this paper
• Human anti-animal antibody interferences in immunological assays.

  1999cited by this paper
• Etiology of Anti-Animal Antibodies and Mechanism of Interference in

  1999cited by this paper
• Type 1 diabetes.

  1999cited by this paper
• Printed in U.S.A. Copyright © 2000 by The Endocrine Society Coexpression of Receptors for Adrenomedullin, Calcitonin Gene-Related Peptide, and Amylin in

  1999cited by this paper
• Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin).

  1998cited by this paper
• A novel micro-assay for insulin autoantibodies.

  1997cited by this paper
• Effects of beta cell granule components on human islet amyloid polypeptide fibril formation

  1996cited by this paper
• Islet amyloid polypeptide and insulin gene expression are regulated in parallel by glucose in vivo in rats.

  1996cited by this paper
• Pore Formation by the Cytotoxic Islet Amyloid Peptide Amylin (*)

  1996cited by this paper
• Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of an islet amyloid polypeptide-like molecule

  1993cited by this paper
• Evidence for selective release of rodent islet amyloid polypeptide through the constitutive secretory pathway

  1993cited by this paper
• Detection of autoantibodies against islet amyloid polypeptide in human serum. Lack of association with Type 1 (insulin-dependent) diabetes mellitus, or with conditions favouring amyloid deposition in islets

  1992cited by this paper
• Failure to detect autoantibodies to islet amyloid polypeptide in sera from type 1 diabetic patients.

  1992cited by this paper
• Failure to detect autoantibodies to islet amyloid polypeptide in sera from type 1 diabetic patients.

  1992cited by this paper
• Glucose Stimulates and Potentiates Islet Amyloid Polypeptide Secretion by the B-Cell

  1991cited by this paper
• Autoantibodies to Islet Amyloid Polypeptide in Diabetes

  1991cited by this paper
• Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells.

  1990cited by this paper
• Evidence of Cosecretion of Islet Amyloid Polypeptide and Insulin by β-Cells

  1990cited by this paper
• Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.

  1987cited by this paper
• A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas.

  1986cited by this paper
• Type I diabetes mellitus. A chronic autoimmune disease.

  1986cited by this paper
• Type I diabetes mellitus. A chronic autoimmune disease.

  1986cited by this paper
• In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.

  1985cited by this paper

• The story of amylin: from physiology to therapy

  2026cites this paper
• Integrative gene target mapping, RNA sequencing, in silico molecular docking, ADMET profiling and molecular dynamics simulation study of marine derived molecules for type 1 diabetes mellitus.

  2026cites this paper
• Biomarkers, Proteoforms, and Mass Spectrometry–Based Assays for Diabetes Clinical Research

  2025cites this paper
• Rodent islet amyloid polypeptide (IAPP) selectively enhances GABAA receptor-mediated neuronal inhibition in mouse ventral but not dorsal hippocampal dentate gyrus granule cells

  2025cites this paper
• Decoding the Contribution of IAPP Amyloid Aggregation to Beta Cell Dysfunction: A Systematic Review and Epistemic Meta-Analysis of Type 1 Diabetes

  2025influential citation
• New horizon of the combined BCG vaccine with probiotic and liraglutide in augmenting beta cell survival via suppression of TXNIP/NLRP3 pyroptosis signaling in Streptozocin–Induced diabetes mellitestype-1 in rats

  2024cites this paper
• Selected Serum Markers Associated with Pathogenesis and Clinical Course of Type 1 Diabetes in Pediatric Patients—The Effect of Disease Duration

  2023cites this paper
• Setting the Stage for Insulin Granule Dysfunction during Type-1-Diabetes: Is ER Stress the Culprit?

  2022cites this paper
• Amylin Dyshomeostasis Hypothesis: Small Vessel-Type Ischemic Stroke in the Setting of Type-2 Diabetes.

  2021cites this paper
• β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances

  2021cites this paper
• Islet amyloid toxicity: From genesis to counteracting mechanisms

  2021cites this paper
• Nonhuman IAPP Variants Inhibit Human IAPP Aggregation.

  2021cites this paper
• Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis

  2021cites this paper
• Marginal Transplantation Dose Study for the Treatment of Insulin-independent Type 1 Diabetes After Allogeneic Islet Transplantation in Macaca Fascicularis Monkeys

  2021cites this paper
• Optimal allogeneic islet dose for transplantation in insulin-dependent diabetic Macaca fascicularis monkeys

  2021cites this paper
• Mechanisms of Transthyretin Inhibition of IAPP Amyloid Formation

  2021cites this paper
• The Human Islet Amyloid Polypeptide in Protein Misfolding Disorders: Mechanisms of Aggregation and Interaction with Biomembranes.

  2020cites this paper
• Amyloid fibril structure of islet amyloid polypeptide by cryo-electron microscopy reveals similarities with amyloid beta

  2020cites this paper
• Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-β fibrils

  2020cites this paper
• Glucoregulatory actions of leptin in rodent models of diabetes

  2019cites this paper
• Beta secretase regulation and inflammation in pancreatic β-cells: the potential role of Rooibos

  2018cites this paper
• Type 1 Diabetes: an Association Between Autoimmunity, the Dynamics of Gut Amyloid-producing E. coli and Their Phages

  2018cites this paper
• IAPP and type 1 diabetes: implications for immunity, metabolism and islet transplants.

  2018cites this paper
• Elucidating the multi-targeted anti-amyloid activity and enhanced islet amyloid polypeptide binding of β-wrapins

  2018cites this paper
• Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism

  2017cites this paper
• Islet amyloid in recent-onset type 1 diabetes—the DiViD study

  2017cites this paper
• Environmental risk factors for type 1 diabetes.

  2016cites this paper
• Neuroendocrine hormone amylin in diabetes.

  2016cites this paper
• Impaired pro-islet amyloid polypeptide processing promotes beta-cell dysfunction in diabetes and islet transplants

  2016cites this paper
• The Role of Human IAPP in Stress and Inflammatory Processes in Type 2 Diabetes

  2016cites this paper
• Plasma and Pancreatic Tissue Levels of Islet Amyloid Polypeptide in Type 1 and Type 2Diabetes: A Review

  2016cites this paper
• Circulating Differentially Methylated Amylin DNA as a Biomarker of β-Cell Loss in Type 1 Diabetes

  2016cites this paper
• Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology

  2015cites this paper